These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 12594628)
1. [Which interactions are there for equal doses of acetylsalicylic acid and ACE inhibitors?]. Joost HG Dtsch Med Wochenschr; 2003 Feb; 128(8):398. PubMed ID: 12594628 [No Abstract] [Full Text] [Related]
2. [Use of aspirin in patients taking angiotensin converting enzyme inhibitors]. Altin T; Kiliçkap M Anadolu Kardiyol Derg; 2007 Dec; 7 Suppl 2():14-9. PubMed ID: 18160362 [TBL] [Abstract][Full Text] [Related]
3. [Acetylsalicylic acid and ACE inhibitors in heart disease--a phenomenon in dogs and cats?]. Bĕlohlávek J; Aschermann M Vnitr Lek; 2002 Aug; 48(8):695-7. PubMed ID: 12425197 [No Abstract] [Full Text] [Related]
5. Letter by Guazzi and Reina regarding article, "Aspirin use and outcomes in a community-based cohort of 7352 patients discharged after first hospitalization for heart failure". Guazzi M; Reina G Circulation; 2007 Jan; 115(4):e54; author reply e55. PubMed ID: 17261667 [No Abstract] [Full Text] [Related]
6. [Pharmacological aspects of secondary prevention post-MI]. Schrör K Z Kardiol; 2004; 93 Suppl 1():I1-3. PubMed ID: 15021997 [TBL] [Abstract][Full Text] [Related]
7. [The long way of angiotensin-converting enzyme inhibitors in the fight against cardiovascular diseases]. Ferrari R; Ambrosio G; Chiariello M Ital Heart J; 2005 Nov; 6 Suppl 7():3S-4S. PubMed ID: 16485511 [No Abstract] [Full Text] [Related]
8. [Efficacy of angiotensin-converting enzyme inhibitors in secondary prevention]. Ceconi C; Mastrorilli F; Squasi PA; Gaitani S; Guardigli G; Ferrari R Ital Heart J; 2005 Nov; 6 Suppl 7():5S-13S. PubMed ID: 16485512 [TBL] [Abstract][Full Text] [Related]
9. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option. Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075 [TBL] [Abstract][Full Text] [Related]
10. [Practical prevention and treatment of cardiovascular diseases in patients with diabetes mellitus type 2 in an endocrinological department]. Daurbekova LV; Orlov VA; Giliarevskiĭ SR; Abirova ES; Murzabekova LI Ter Arkh; 2004; 76(12):32-6. PubMed ID: 15724922 [TBL] [Abstract][Full Text] [Related]
11. Antiplatelet effects of angiotensin-converting enzyme inhibitors compared with aspirin and clopidogrel: a pilot study with whole-blood aggregometry. Bauriedel G; Skowasch D; Schneider M; Andrié R; Jabs A; Lüderitz B Am Heart J; 2003 Feb; 145(2):343-8. PubMed ID: 12595854 [TBL] [Abstract][Full Text] [Related]
12. [Interaction between Trombyl and ACE inhibitor]. Ekstedt B; Mjörndal T Lakartidningen; 2006 Nov 29-Dec 5; 103(48):3842. PubMed ID: 17212249 [No Abstract] [Full Text] [Related]
13. [After coronary intervention. Which platelet inhibitor for whom?]. Stiefelhagen P MMW Fortschr Med; 2007 Apr; 149(14):18-9. PubMed ID: 17668756 [No Abstract] [Full Text] [Related]
14. Controversies in antiplatelet therapy for patients with cardiovascular disease. Bates ER; Lau WC Circulation; 2005 May; 111(17):e267-71. PubMed ID: 15867186 [No Abstract] [Full Text] [Related]
15. [Coronary heart disease patient does not tolerate acetylsalicylic acid. Can clopidogrel be prescribed?]. Rupprecht HJ MMW Fortschr Med; 2007 Apr; 149(14):19. PubMed ID: 17668757 [No Abstract] [Full Text] [Related]
16. Even low-dose aspirin inhibits arachidonic acid-induced vasodilation in heart failure. Davie AP; Love MP; McMurray JJ Clin Pharmacol Ther; 2000 May; 67(5):530-7. PubMed ID: 10824632 [TBL] [Abstract][Full Text] [Related]
17. [Is it recommended simultaneous use of acetylsalicylic acid and angiotensin converting enzyme inhibitors?]. Głuszek J; Tykarski A; Jankowska K Pol Arch Med Wewn; 2005 Sep; 114(3):906-12. PubMed ID: 16708567 [No Abstract] [Full Text] [Related]